BHST: BioHarvest Sciences Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 103.62
Enterprise Value ($M) 99.62
Book Value ($M) 6.70
Book Value / Share 0.39
Price / Book 15.46
NCAV ($M) -11.06
NCAV / Share -0.64
Price / NCAV -9.37

Profitability (mra)
Return on Invested Capital (ROIC) -0.95
Return on Assets (ROA) -1.53
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.75
Current Ratio 1.04

Balance Sheet (mrq) ($M)
Current Assets 9.26
Assets 27.01
Liabilities 20.31
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 10,377 38,637 26.86
2024-11-14 3,850 26,009 14.80
2024-11-13 2,700 35,441 7.62

(click for more detail)

Similar Companies
AVTE – Aerovate Therapeutics, Inc. AXSM – Axsome Therapeutics, Inc.
BCAB – BioAtla, Inc. BIOR – Biora Therapeutics, Inc.
BTMD – biote Corp.


Financial data and stock pages provided by
Fintel.io